Market Opportunity – Cell Therapy Research

March 8, 2011
60 Views

Neurological disorders or injuries are those affecting the central nervous system (brain and spinal cord) or peripheral nervous system (PNS). Neurodegenerative diseases primarily involve neural deterioration. Causes can include: traumatic brain, spinal cord or nerve injury, genetic disorders, congenital abnormality or disorders, infections, and lifestyle or environmental health problems (including malnutrition).

 

Neurological disorders or injuries are those affecting the central nervous system (brain and spinal cord) or peripheral nervous system (PNS). Neurodegenerative diseases primarily involve neural deterioration. Causes can include: traumatic brain, spinal cord or nerve injury, genetic disorders, congenital abnormality or disorders, infections, and lifestyle or environmental health problems (including malnutrition).

 

Neurology

 

Structural, biochemical or electrical abnormalities in the brain or spinal cord, or in the nerves leading to or from them, can result in symptoms such as paralysis, muscle weakness, poor coordination, loss of sensation, seizures, confusion, pain and altered levels of consciousness.

Disorders in neurology that represent targets of cell therapy research include stroke, Parkinson’s Disease, Alzheimer’s Disease, epilepsy, traumatic brain injury, central nervous system and spinal cord diseases — amyotropic lateral sclerosis (Lou Gehrig’s Diseas), multiple sclerosis, neuromuscular/muscular dystrophy). 

Considering only the numbers of Americans, there is a large population of potential patients:

  • Stroke: 700,000 per year
  • Parkinson’s:  4.5 million prevalence
  • Alzheimer’s: 1 million prevalence
  • Epilepsy: 200,00 per year
  • Traumatic brain injury: 1.4 million prevalence
  • Central nervous system and spinal cord disease: 1 million prevalence 

Companies with active product development for cell therapy in neurological applications include: Aastrom Bioscience Inc., Aeolus Pharmaceuticals, Aldagen, Inc., Athersys, Inc., BeFutur Biotechnologies, BrainStorm Cell Therapeutics, Inc., co.don AG, ES Cell International, Geron Corporation, Innogenetics, Integra LifeSciences Inc., Living Cell Technologies Ltd., Medtronic, Neuralstem, Inc., NeuroGeneration, Inc., NeuroNova AB, Osteotech, Pluristem Therapeutics, Inc., Polyganics BV, ProNeuron Biotechnologies, Inc., ReInnervate Ltd., ReNeuron Ltd., Sernova Corp., Stem Cell Pharma Inc., StemCells Inc., Targeted Genetics Corporation, TEI Biosciences Inc., Transition Therapeutics Inc, and TriStem Corporation.

Data on cell and tissue engineering therapy markets and products under development is provided in MedMarket Diligence Report #S520, “Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities, Worldwide, 2009-2018.”

 

 

Posted via email from medmarket’s posterous


     

You may be interested

Can Natural Remedies Like RediCalm Decrease Stress and Anxiety?
Wellness
2 views
Wellness
2 views

Can Natural Remedies Like RediCalm Decrease Stress and Anxiety?

Ryan Kh - August 16, 2017

According to research from the National Institute of Mental Health, anxiety disorders are the most common mental illness in the…

How to Alleviate Stress Related Insomnia
Specialties
400 views
Specialties
400 views

How to Alleviate Stress Related Insomnia

JohnHenning - August 15, 2017

Do you have difficulty falling asleep or staying asleep every night? You aren't alone. According to multiple studies, including one…

4 Hormones That Play a Critical Role in Your Well being
Wellness
437 views
Wellness
437 views

4 Hormones That Play a Critical Role in Your Well being

Erica - August 15, 2017

Hormonal health and wellbeing have received plenty of attention lately, both from the medical community as well as from health-conscious…